Sandbox: sadaf: Difference between revisions

Jump to navigation Jump to search
Ssharfaei (talk | contribs)
Ssharfaei (talk | contribs)
Line 81: Line 81:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!Aplastic anemia
! align="center" style="background:#DCDCDC;" + |Aplastic anemia
!
!
| +
| +
Line 111: Line 111:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!Acute leukemia
! align="center" style="background:#DCDCDC;" + |Acute leukemia
!
!
| +
| +
Line 141: Line 141:
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
!Paroxysmal nocturnal hemoglobinuria (PNH)
! align="center" style="background:#DCDCDC;" + |Paroxysmal nocturnal hemoglobinuria (PNH)
!
!
| +
| +
Line 171: Line 171:
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! rowspan="2" |'''Thrombotic microangiopathy (TMA)'''
! rowspan="2" align="center" style="background:#DCDCDC;" + |Thrombotic microangiopathy (TMA)
!Thrombotic thrombocytopenic purpura (TTP)
! align="center" style="background:#DCDCDC;" + |Thrombotic thrombocytopenic purpura (TTP)
!
!
!
!
Line 202: Line 202:
!
!
|-
|-
!Hemolytic uremic syndrome (HUS)
! align="center" style="background:#DCDCDC;" + |Hemolytic uremic syndrome (HUS)
!
!
!
!
Line 233: Line 233:
|-
|-
!
!
!DIC
! align="center" style="background:#DCDCDC;" + |DIC
!
!
!
!
Line 474: Line 474:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!'''Nutrient deficiencies'''
! align="center" style="background:#DCDCDC;" + |Nutrient deficiencies
!Folate, vitamin B12, copper
! align="center" style="background:#DCDCDC;" + |Folate, vitamin B12, copper
|an autoimmune mechanism
|an autoimmune mechanism
!+
!+
Line 538: Line 538:
|-
|-
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rheumatologic/autoimmune disorders
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rheumatologic/autoimmune disorders
!Immune thrombocytopenia
! align="center" style="background:#DCDCDC;" + |Immune thrombocytopenia
!
!
|Antibody-mediated platelet destruction
|Antibody-mediated platelet destruction
Line 569: Line 569:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!Systemic lupus erythematosus (SLE)
! align="center" style="background:#DCDCDC;" + |Systemic lupus erythematosus (SLE)
!
!
!
!
Line 600: Line 600:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!Antiphospholipid syndrome (APS)
! align="center" style="background:#DCDCDC;" + |Antiphospholipid syndrome (APS)
!
!
!autoantibody-mediated syndrome
!autoantibody-mediated syndrome
Line 631: Line 631:
!
!
|-
|-
!Felty's syndrome
! align="center" style="background:#DCDCDC;" + |Felty's syndrome
!
!
!splenomegaly
!splenomegaly
Line 754: Line 754:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
! rowspan="2" |Viral infections
! rowspan="2" align="center" style="background:#DCDCDC;" + |Viral infections
!HIV
! align="center" style="background:#DCDCDC;" + |HIV
!
!
* Direct toxicity to megakaryocytes
* Direct toxicity to megakaryocytes
Line 788: Line 788:
!
!
|-
|-
!Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus
! align="center" style="background:#DCDCDC;" + |Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus
!
!
!+
!+
Line 913: Line 913:
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medication/toxicity
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medication/toxicity
! align="center" style="background:#DCDCDC;" + |Drug-induced immune thrombocytopenia
! align="center" style="background:#DCDCDC;" + |Drug-induced immune thrombocytopenia
!
! align="left" style="background:#DCDCDC;" + |
* Antibiotics  
* Antibiotics  
** Sulfonamides
** Sulfonamides
Line 953: Line 953:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!'''Heparin-induced thrombocytopenia'''
! align="center" style="background:#DCDCDC;" + |Heparin-induced thrombocytopenia
!
!
|
|
Line 984: Line 984:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!Cytotoxic chemotherapy
! align="center" style="background:#DCDCDC;" + |Cytotoxic chemotherapy
!
!
|
|
Line 1,015: Line 1,015:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!'''Radiation therapy'''
! align="center" style="background:#DCDCDC;" + |Radiation therapy
!
!
|Predictable, dose-dependent myelosuppression
|Predictable, dose-dependent myelosuppression
Line 1,046: Line 1,046:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!OTC agents
! align="center" style="background:#DCDCDC;" + |OTC agents
!Quinine-containing beverages
! align="center" style="background:#DCDCDC;" + |Quinine-containing beverages
|
|
|
|
Line 1,078: Line 1,078:
|-
|-
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI
!Chronic liver disease
! align="center" style="background:#DCDCDC;" + |Chronic liver disease
!
!
|
|
Line 1,109: Line 1,109:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
!Portal hypertension
! align="center" style="background:#DCDCDC;" + |Portal hypertension
!
!
|
|
Line 1,173: Line 1,173:
|-
|-
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vascular  
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vascular  
!Giant capillary hemangioma  
! align="center" style="background:#DCDCDC;" + |Giant capillary hemangioma  
!
!
!platelet destruction  
!platelet destruction  
Line 1,204: Line 1,204:
!
!
|-
|-
!Aortic aneurysm  
! align="center" style="background:#DCDCDC;" + |Aortic aneurysm  
!
!
!platelet destruction  
!platelet destruction  
Line 1,235: Line 1,235:
!
!
|-
|-
!Cardiopulmonary bypass
! align="center" style="background:#DCDCDC;" + |Cardiopulmonary bypass
!
!
!platelet destruction  
!platelet destruction  
Line 1,267: Line 1,267:
|-
|-
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
!Alcohol
! align="center" style="background:#DCDCDC;" + |Alcohol
!
!
!
!
Line 1,298: Line 1,298:
!
!
|-
|-
!Post-transfusion purpura
! align="center" style="background:#DCDCDC;" + |Post-transfusion purpura
!
!
!immune-mediated platelet destruction
!immune-mediated platelet destruction
Line 1,329: Line 1,329:
!
!
|-
|-
!Gestational thrombocytopenia
! align="center" style="background:#DCDCDC;" + |Gestational thrombocytopenia
!
!
!
!

Revision as of 22:10, 14 August 2018

Thrombocytopenia Differential Diagnosis

Differentiating the diseases that can cause thrombocytopenia:

Category Condition Mechanism Mechanism Inherited Acquried Clinical manifestations Para−clinical findings Gold standard Associated findings
Age range History Symptoms Signs
Lab Findings Imaging
Severity Fever Rash Bleeding BP Splenomegaly Jaundice Other CBC PBS Bone marrow exam PT PTT BT UA
Decreased platelet production Platelet destruction in bloodstream Platelet destruction in spleen/liver Plt HB WBC
Hematology Bone marrow disorders Myelodysplastic syndromes +
Aplastic anemia +
Acute leukemia +
Paroxysmal nocturnal hemoglobinuria (PNH) + Diagnosis of exclusion
Thrombotic microangiopathy (TMA) Thrombotic thrombocytopenic purpura (TTP) +
Hemolytic uremic syndrome (HUS) +
DIC
Congenital platelet disorders MYH-9 related disorders
Bernard-Soulier syndrome
Gray platelet syndrome
Wiskott-Aldrich syndrome
Thrombocytopenia with absent radius (TAR) syndrome
Alport syndrome
Von Willebrand disease
Nutrient deficiencies Folate, vitamin B12, copper an autoimmune mechanism +
Category Condition Mechanism Decreased platelet production Platelet destruction in bloodstream Platelet destruction in spleen/liver Inherited Acquried Age range History Severity Fever Rash Bleeding BP Splenomegaly Jaundice Other signs Plt HB WBC PBS Bone marrow exam PT PTT BT UA Imaging Gold standard Associated findings
Rheumatologic/autoimmune disorders Immune thrombocytopenia Antibody-mediated platelet destruction + Moderate to severe -
Systemic lupus erythematosus (SLE)
Antiphospholipid syndrome (APS) autoantibody-mediated syndrome
Felty's syndrome splenomegaly
Infection-induced Bacterial infections Sepsis Direct bone marrow suppression + +
Helicobacter pylori Immune thrombocytopenia +
Tick-borne infection +
Viral infections HIV
  • Direct toxicity to megakaryocytes
  • An ITP-like condition called primary HIV-associated thrombocytopenia (PHAT)
  • Secondary opportunistic infections
+
Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus +
Intracellular parasites Malaria
Babesiosis
Category Condition Mechanism Decreased platelet production Platelet destruction in bloodstream Platelet destruction in spleen/liver Inherited Acquried Age range History Severity Fever Rash Bleeding BP Splenomegaly Jaundice Other signs Plt HB WBC PBS Bone marrow exam PT PTT BT UA Imaging Gold standard Associated findings
Medication/toxicity Drug-induced immune thrombocytopenia
  • Antibiotics
    • Sulfonamides
    • Ampicillin
    • Piperacillin
    • Vancomycin
    • Rifampin
  • Older antiepileptic agents
    • carbamazepine
    • Phenytoin
  • Quinine
Occurrence of drug-dependent, platelet-reactive antibodies +
Heparin-induced thrombocytopenia +
Cytotoxic chemotherapy +
Radiation therapy Predictable, dose-dependent myelosuppression +
OTC agents Quinine-containing beverages
GI Chronic liver disease + Mild
Portal hypertension
Category Condition Mechanism Decreased platelet production Platelet destruction in bloodstream Platelet destruction in spleen/liver Inherited Acquried Age range History Severity Fever Rash Bleeding BP Splenomegaly Jaundice Other signs Plt HB WBC PBS Bone marrow exam PT PTT BT UA Imaging Gold standard Associated findings
Vascular Giant capillary hemangioma platelet destruction +
Aortic aneurysm platelet destruction +
Cardiopulmonary bypass platelet destruction +
Other Alcohol +
Post-transfusion purpura immune-mediated platelet destruction
Gestational thrombocytopenia +